Ipamorelin's human data is limited to two published pharmacokinetic/pharmacodynamic studies: a 1999 PK/PD study (PMID: 10496658) that documented dose-response relationships and peak GH at 30-40 minutes post-injection in human volunteers, and a completed Phase II clinical trial for postoperative ileus (NCT00672074), after which ipamorelin's development for this indication was discontinued without approval
There can occasionally be some mismatch in the images and the actual physical product since the brand may update the product labels from time to time
Hernandez LE, Sobrino-Plata J, Montero-Palmero MB, Carrasco-Gil S, Flores-Caceres ML, Ortega-Villasante C, Escobar C
All were due to gastrointestinal disorders occurring within the first 3 days of dosing
It is taken as a tablet once per day
A peptide half-life chart is a reference tool used by laboratory researchers to quickly compare how long different peptides remain biologically active in plasma or buffer systems